Results 21 to 30 of about 20,954 (250)

The genetic profile and molecular subtypes of human pseudomyxoma peritonei and appendiceal mucinous neoplasms: a systematic review

open access: yesCancer Metastasis Review, 2023
Pseudomyxoma peritonei (PMP) is a rare, progressive, slowly growing neoplastic condition which is poorly understood, with a 5-year progression-free survival rate as low as 48%.
Nora Wangari Murage   +4 more
semanticscholar   +1 more source

The Role of Hyperthermic Intraperitoneal Chemotherapy in Pseudomyxoma Peritonei After Cytoreductive Surgery.

open access: yesJAMA Surgery, 2021
Importance Studies on the prognostic role of hyperthermic intraperitoneal chemotherapy (HIPEC) in pseudomyxoma peritonei (PMP) are currently not available.
S. Kusamura   +22 more
semanticscholar   +1 more source

Pseudomyxoma Peritonei Secondary to Rupture of Intraductal Papillary Neoplasm of Pancreas (IPMN) [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2018
Pseudomyxoma peritonei is the intraperitoneal accumulation of a gelatinous ascites secondary to mucinous tumour rupture, more commonly associated with ovarian and appendiceal mucinous tumour.
Saurabh Kumar, Alok Kumar mittal
doaj   +1 more source

Mucocèle appendiculaire

open access: yesAvicenna Medical Research, 2022
Appendicular mucocele is a rare condition defined by a mucinous distention of the appendicular lumen. The most severe complication is the intra-peritoneum rupture also called pseudomyxoma peritonei.
R BELOUZ   +5 more
doaj   +1 more source

Pseudomyxoma Peritonei [PDF]

open access: yesKlinicka Onkologie, 2019
Pseudomyxoma peritonei is a rare tumorous disease with various grades of malignancy and is characterized by production of mucinous and gelatinous masses. Development of pseudomyxoma peritonei is usually associated with rupture of appendiceal mucinous tumors and other mucinous tumors of the gastrointestinal tract or ovaries.
Petr, Bartoška   +5 more
openaire   +2 more sources

Serum and ascites tumor markers in the diagnostic and prognostic prediction for appendiceal pseudomyxoma peritonei

open access: yesBMC Cancer, 2023
Background To investigate the expression of carcinoembryonic antigen (CEA), cancer antigen 199 (CA199) and CA125 in serum and ascites of appendiceal pseudomyxoma peritonei (PMP) patients relative to their diagnostic and predictive value.
Bing Wang, R. Ma, B. Rao, Hongbin Xu
semanticscholar   +1 more source

Four cases of pseudomyxoma peritonei with ovarian tumors at our hospital

open access: yesFukushima Journal of Medical Science, 2023
We describe four cases of pseudomyxoma peritonei (PMP) that were diagnosed and treated at our hospital. Case 1: A 26-year-old woman with a large multicystic ovarian tumor and massive ascites was diagnosed with PMP originating from a borderline mucinous ...
Riho Yazawa   +4 more
semanticscholar   +1 more source

The Delphi and GRADE methodology used in the PSOGI 2018 consensus statement on Pseudomyxoma Peritonei and Peritoneal Mesothelioma

open access: yes, 2021
Pseudomyxoma Peritonei (PMP) and Peritoneal Mesothelioma (PM) are both rare peritoneal malignancies. Currently, affected patients may be treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy offering long-term survival or even ...
de Hingh, I.,   +12 more
core   +1 more source

Under the Hood: Understanding the Features of Mucin in Pseudomyxoma Peritonei

open access: yesJournal of Clinical Medicine, 2023
Pseudomyxoma peritonei (PMP) is a rare malignant growth characterized by the production of mucin and the potential for peritoneal relapse. This study aimed to investigate the immunohistochemical and biological characteristics of mucin in patients with ...
P. Villarejo-Campos   +9 more
semanticscholar   +1 more source

Pseudomyxoma Peritonei [PDF]

open access: yesJournal of the Royal Society of Medicine, 1986
In pseudomyxoma peritonei, mucinous implants develop on peritoneal surfaces and omentum, often resulting in gelatinous ascites. Definitive treatment has not been established. Adjunctive radiation therapy or chemotherapy following laparotomy has improved survival in some patients.
J S, Friedland   +2 more
openaire   +4 more sources

Home - About - Disclaimer - Privacy